NDC 70771-1742-1 - vigabatrin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1742
- Requested NDC
- 70771-1742-1
- Package NDCs from labels
- 70771-1742-1, 70771-1742-8
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2025-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| vigabatrin - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2025-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1742-1 | vigabatrin | 10 mL in 1 PACKET | POWDER, FOR SOLUTION | 10 | 2 | |
| 70771-1742-8 | vigabatrin | 50 in 1 CARTON | POWDER, FOR SOLUTION | 50 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1742 | VIGABATRIN POWDER, FOR SOLUTION [ZYDUS LIFESCIENCES LIMITED] | 1 | Current NDC, 2 package rows | 20250325_cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vigabatrin | VIGABATRIN | Edenbridge Pharmaceuticals LLC. | 93ba3894-fd97-4432-9f2d-e7050371e91f | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| VIGADRONE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 5e5e7554-d0f4-47f7-a434-cc5ca5a9826f | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| Vigabatrin | VIGABATRIN | Novadoz Pharmaceuticals LLC | 082d818a-4f4e-4675-98c6-91db0294e63c | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| vigabatrin | VIGABATRIN | Carnegie Pharmaceuticals LLC | 8406bd5a-8887-4579-a11e-5ab449c58963 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| VIGABATRIN | VIGABATRIN | Par Health USA, LLC | e7cbc0a5-8c28-4451-9176-b608e228ba66 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| vigabatrin | VIGABATRIN | Zydus Lifesciences Limited | cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | ANDA214671 70771-1742-1 70771-1742-8 70771-1742 70771174201 250820 2fd46d14-d59a-4335-9f92-9e029defc7b2 cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c GR120KRT6K |
| vigabatrin | VIGABATRIN | Zydus Lifesciences Limited | e9c99000-fc0c-4083-b620-ba9ac821f8ac | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| VIGAFYDE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 8d3d6316-33ab-41e8-9485-4495c218be56 | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| Vigabatrin | VIGABATRIN | Aurobindo Pharma Limited | c97ce40c-1c5a-479d-9188-5ce03cf7e065 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| VIGADRONE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 01f7f049-78c2-47c2-a66e-ec662ba48a98 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| Vigabatrin | VIGABATRIN | Actavis Pharma, Inc. | 8dc7bd15-2636-4d58-b651-dd117ca43dbd | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| Vigabatrin | VIGABATRIN | Dr. Reddys Laboratories Inc., | f6be436e-46c7-e9ab-0fcf-e8d04dc12b72 | 2024-06-07 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| vigabatrin for oral solution | VIGABATRIN | Camber Pharmaceuticals, Inc. | bda491b6-47ba-400b-9816-b6d15c6e2683 | 2024-04-22 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| vigabatrin | VIGABATRIN | Zydus Pharmaceuticals (USA) Inc. | 6d3fc853-1b2d-47ad-a4f2-f11505601bc2 | 2024-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA214671 250820 GR120KRT6K |
| vigabatrin | VIGABATRIN | Zydus Pharmaceuticals (USA) Inc. | 6c0bf4fb-b234-4053-9163-1e8d0142d718 | 2024-03-21 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| Vigabatrin | VIGABATRIN | Aurobindo Pharma Limited | 4aaea88b-e0fd-45e3-bb02-604bf8ee9b5b | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
| Vigabatrin | VIGABATRIN | Amneal Pharmaceuticals NY LLC | 9791494f-492b-487a-8211-7747fb57923e | 2023-02-28 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| Vigabatrin | VIGABATRIN | Amneal Pharmaceuticals NY LLC | 5b8fb137-848b-45fd-9107-a6db5a675360 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| VIGABATRIN | VIGABATRIN | Ascend Laboratories, LLC | ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8 | 2022-11-16 | Boxed warning, Warnings, Adverse reactions | 250820 GR120KRT6K |
| Vigabatrin | VIGABATRIN | Hikma Pharmaceuticals USA Inc | 5ed8d293-b7d8-4c66-9c31-8075e6f99092 | 2022-08-11 | Boxed warning, Warnings, Adverse reactions | GR120KRT6K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.